Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
Abel K, Compton L, Rourke T, Montefiori D, Lu D, Rothaeusler K, Fritts L, Bost K, Miller CJ. Abel K, et al. J Virol. 2003 Mar;77(5):3099-118. doi: 10.1128/jvi.77.5.3099-3118.2003. J Virol. 2003. PMID: 12584336 Free PMC article.
High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.
LaFranco-Scheuch L, Abel K, Makori N, Rothaeusler K, Miller CJ. LaFranco-Scheuch L, et al. Among authors: abel k. J Virol. 2004 Jun;78(12):6399-408. doi: 10.1128/JVI.78.12.6399-6408.2004. J Virol. 2004. PMID: 15163733 Free PMC article.
In an attenuated vaccine model, approximately 60% of animals immunized with simian/human immunodeficiency virus (SHIV) 89.6 and then challenged intravaginally with SIVmac239 controlled viral replication (viral RNA level in plasma, <10(4) copies/ml) and were considered protecte …
In an attenuated vaccine model, approximately 60% of animals immunized with simian/human immunodeficiency virus (SHIV) 89.6 and then challen …
Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef.
Kim EY, Busch M, Abel K, Fritts L, Bustamante P, Stanton J, Lu D, Wu S, Glowczwskie J, Rourke T, Bogdan D, Piatak M Jr, Lifson JD, Desrosiers RC, Wolinsky S, Miller CJ. Kim EY, et al. Among authors: abel k. J Virol. 2005 Apr;79(8):4886-95. doi: 10.1128/JVI.79.8.4886-4895.2005. J Virol. 2005. PMID: 15795274 Free PMC article.
Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
Busch M, Abel K, Li J, Piatak M Jr, Lifson JD, Miller CJ. Busch M, et al. Among authors: abel k. Vaccine. 2005 Jul 1;23(31):4036-47. doi: 10.1016/j.vaccine.2005.03.013. Epub 2005 Apr 9. Vaccine. 2005. PMID: 15963361
Sixty percent of rhesus macaques infected with virulence attenuated virus SHIV 89.6 are protected from subsequent intravaginal challenge with pathogenic SIVmac239 [Abel K, Compton L, Rourke T, Montefiori D, Lu D, Rothaeusler K, et al. Simian-human immunodefic …
Sixty percent of rhesus macaques infected with virulence attenuated virus SHIV 89.6 are protected from subsequent intravaginal challenge wit …
534 results